Form EFFECT BriaCell Therapeutics
| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | January 13, 2026 5:00 P.M. |
| Form: | S-1 | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- J.P. Morgan Asset Management Announces Rebrand of Campbell Global to J.P. Morgan Natural Capital
- MFour Expands Digital Ad Exposure Intelligence to ChatGPT and Audio Streaming Platforms
- Rosina Foods Launches Five New Frozen Meatball Innovations Nationwide
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share